发明名称 Method for combined conditioning and chemoselection in a single cycle
摘要 A method of radiation-free hematopoietic stem cell (HSC) transplantation comprises administering to a mammalian subject one or two doses of 2 to 10 mg/kg body weight of a purine base analog, such as 6TG as a pre-conditioning step. The method further comprises engrafting into the subject hypoxanthine-guanine phosphoribosyltransferase (HPRT)-deficient donor HSCs within 48 to 72 hours of the pre-conditioning step; and administering to the subject about 1 to 5 mg/kg of the purine base analog every two to four days for two to eight weeks following the engrafting step. The method is performed in the absence of pre-conditioning via radiation. The subject is therefore not treated with myeloablative radiation in preparation for transplantation, and thus the subject is free of myeloablative radiation-induced toxicity.
申请公布号 US9439928(B2) 申请公布日期 2016.09.13
申请号 US201214112878 申请日期 2012.04.20
申请人 THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 发明人 Kasahara Noriyuki;Schiestl Robert H.;Hacke Katrin;Szakmary Akos;Crooks Gay M.
分类号 A61K35/28;A61K31/52;A61K31/7076;C12N5/10;C12N5/0789;A61K35/14 主分类号 A61K35/28
代理机构 Canady + Lortz LLP 代理人 Canady Karen S.;Canady + Lortz LLP
主权项 1. A method of radiation-free hematopoietic stem cell (HSC) transplantation, the method comprising: (a) administering to a mammalian subject one or two doses of 2 to 10 mg/kg body weight of a purine base analog selected from 6-thioguanine (6TG), 6-mercaptopurine (6-MP), or azathiopurine (AZA), as a pre-conditioning step; (b) engrafting into the subject hypoxanthine-guanine phosphoribosyltransferase (HPRT)-deficient donor HSCs within 48 to 72 hours of the pre-conditioning step; and (c) immediately administering to the subject about 1 to 5 mg/kg of the purine base analog every two to four days for two to eight weeks without allowing for a recovery period; wherein the method is performed in the absence of pre-conditioning via radiation.
地址 Oakland CA US